Combizym 康彼身 消化酵素 | 消化不良不再只靠胃藥

About Aspergillus oryzae

Combizym® tablets feature a dual-layer coating designed to support stable, site-specific release of digestive enzymes as the tablet moves through the digestive system.1,7

Aspergillus oryzae is a well-established source of digestive enzymes commonly used in enzyme preparations to support the breakdown of food.13

How Combizym® Supports Digestion

~90%

effective for indigestion relief clinically proven

What does the evidence say?

In a randomised clinical study, Combizym® showed an overall efficacy rate of ~ 90% in relieving indigestion symptoms compared with placebo, and was well tolerated.1,7

~90%

effective for indigestion relief clinically proven

What does the evidence say?

In a randomised clinical study, Combizym® showed an overall efficacy rate of ~ 90% in relieving indigestion symptoms compared with placebo, and was well tolerated.1,7

Support Digestion. Maintain Balance. Nourish Well-being.

When digestion works well, your body can make better use of the nutrients you eat, supporting everyday comfort and balance.Designed to work with your body’s natural digestive process, Combizym® supports digestive enzyme activity and help with digestive disorder.1,18

Where to buy

Support Digestion. Maintain Balance. Nourish Well-being.

When digestion works well, your body can make better use of the nutrients you eat, supporting everyday comfort and balance.Designed to work with your body’s natural digestive process, Combizym® supports digestive enzyme activity and help with digestive disorder.1,18

Where to buy

The content here is for information purposes only and does not constitute medical advice. Consult a healthcare professional if symptoms persist or worsen. References:1. Combizym® Prescribing Information (Oct 2021). 2. National Institute of Diabetes and Digestive and Kidney Diseases. Your digestive system and how it works. Available at https://www.niddk.nih.gov/health-information/digestive-diseases/digestive-system-how-it-works. Accessed on 23 January 2026. 3. Tian C, et al. Pancreatic insufficiency. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. 4. Ianiro G, et al. Curr Drug Metab. 2016;17(2):187–93. 5. Shandro BM, et al. World J Gastrointest Pharmacol Ther. 2018;9(5):39–46. 6. Garg V, et al. J Int Med Res. 2022;50(3):3000605221086457. 7. Ran ZH, et al. J Dig Dis. 2009;10(1):41–8. 8. Gaviscon® Double Action Mint PL Prescribing Information. Dated September 2018. 9. NICE Guideline. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Available at www.nice.org.uk/guidance/cg184. Accessed on 6 November 2025. 10. NHS. Antacids. Available at https://www.nhs.uk/medicines/antacids/. Accessed on 6 November 2025. 11. Zantac 360® Prescribing Information. Dated May 2025. 12. Nugent CC, et al. H2 Blockers. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. 13. Daba GM, et al. Bioresour Bioprocess. 2021;8(1):52. 14. Shintakuya R, et al. Pancreatology, Vol. 17, Issue 1, 2017 15. Mounsey, A et al. American Family Physician, Vol. 101 No. 2, 2020 16. McNamara D.A., et al. Gastroenterology Clinics of North America, Vol. 29 Issue 4, 2020. 17. Robinson M, et al. Aliment Pharmacol Ther. 2002 Mar;16(3):435-43 18. Digestive Health: What is Digestive Health?, Journal of Nutrition. https://journalofnutrition.org/encyclopedia/what-is-digestive-health/ Accessed 23 April 2026

Rxilient Health

ABOUT US
Rxilient offers full value-chain capabilities, ranging from registration and commercialization to manufacturing and supply chain management. We partner with innovators and multinationals to develop and commercialize market-leading medicines.

Rxilient Health

ABOUT US
Rxilient offers full value-chain capabilities, ranging from registration and commercialization to manufacturing and supply chain management. We partner with innovators and multinationals to develop and commercialize market-leading medicines.


© combizym.com All rights reserved. COM/HKG/DOC/277/2026/rev.01

© combizym.com All rights reserved.COM/HKG/DOC/277/2026/rev.01